Irisin in adolescent type 1 diabetic patients and its relation to diabetes control and atherosclerosis

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

AIM: The objective of the study was to determine the role of irisin in adolescent type 1 diabetic patients. PATIENTS AND METHODS: Sixty-five type 1 diabetic patients and 50 healthy volunteers were enrolled in the study. Serum irisin, glycosylated hemoglobin (HbA1c), lipid profile, oxidized low-density lipoprotein (OxLDL), urinary albumin/creatinine ratio, carotid intimal-medial thickness (cIMT), and aortic intimal medial thickness (aIMT) were assessed for all participants in the study. RESULTS: HbA1c, albumin/creatinine ratio, lipid profile, OxLDL, irisin, cIMT, and aIMT were significantly higher in diabetic patients. Irisin had a positive correlation with age of diabetic patients, onset of diabetes, mid-arm circumference, waist/height ratio, body mass index, HbA1c, and cIMT. CONCLUSION: Irisin is a marker for detection of diabetes control and early detection of subclinical atherosclerosis. Irisin had a relation with obesity.

Cite

CITATION STYLE

APA

El Dayem, S. M. A., Battah, A. A., El Bohy, A. E. M., & Yousef, R. N. (2020). Irisin in adolescent type 1 diabetic patients and its relation to diabetes control and atherosclerosis. Open Access Macedonian Journal of Medical Sciences, 8, 1262–1265. https://doi.org/10.3889/OAMJMS.2020.5640

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free